Optherion Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
2ndary - Private
Optherion General Information
Description
Operator of a biotechnology company intended for the advancement of diagnostic tools and disease-modifying therapeutics. The company is aimed at effectively managing and treating early-stage age-related macular degeneration, dense deposit disease, also known as membranoproliferative glomerulonephritis, atypical hemolytic uremic syndrome, and other chronic diseases associated with the alternative complement cascade, enabling scientific researchers that have identified specific genes linked to various renal diseases and prevalent among individuals over the age of 60 in developed countries, stands as the primary cause of blindness.
Contact Information
Website
www.optherion.com(Operating Subsidiary)
Corporate Office
- 11th Floor 555 Long Wharf Drive
- The Maritime Center
- New Haven, CT 06511
- United States
Corporate Office
- 11th Floor 555 Long Wharf Drive
- The Maritime Center
- New Haven, CT 06511
- United States
Optherion Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 01-Jun-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 16-Sep-2009 | Completed | Generating Revenue | |||
| 5. Merger/Acquisition | 31-Mar-2009 | Completed | Startup | |||
| 4. Early Stage VC | 14-Jan-2009 | Completed | Startup | |||
| 3. Grant | 01-Jan-2009 | Completed | Startup | |||
| 2. Early Stage VC (Series A1) | 09-Oct-2007 | $37.5M | $37.8M | Completed | Startup | |
| 1. Early Stage VC | 13-Apr-2007 | $250K | $250K | Completed | Startup |
Optherion Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 |
Optherion Signals
Optherion Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biogen | Corporation | Minority | ||
| Domain Associates | Venture Capital | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Knoa Pharma | Corporation | Minority | ||
| Pappas Capital | Venture Capital | Minority |
Optherion FAQs
-
When was Optherion founded?
Optherion was founded in 2005.
-
Where is Optherion headquartered?
Optherion is headquartered in New Haven, CT.
-
What is the size of Optherion?
Optherion has 5 total employees.
-
What industry is Optherion in?
Optherion’s primary industry is Diagnostic Equipment.
-
Is Optherion a private or public company?
Optherion is a Private company.
-
What is Optherion’s current revenue?
The current revenue for Optherion is .
-
How much funding has Optherion raised over time?
Optherion has raised $5M.
-
Who are Optherion’s investors?
Biogen, Domain Associates, Johnson & Johnson JJDC, Knoa Pharma, and Pappas Capital are 5 of 8 investors who have invested in Optherion.
-
When was Optherion acquired?
Optherion was acquired on 01-Jun-2020.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process